by Xcellerant Ventures | Jan 6, 2024 | Xcellerant Ventures News
Origionally posted on Business Wire: https://www.businesswire.com/news/home/20240105587000/en/Xcellerant-Ventures-Ends-First-Year-with-10th-Investment-Leading-CRISPR-QC%E2%80%99s-10-Million-Series-A-Round SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Xcellerant...
by Xcellerant Ventures | Jan 5, 2024 | Portfolio Company News
Originally posted on Business Wire: https://www.businesswire.com/news/home/20240104480597/en/Xcellerant-Ventures-Backs-CRISPR-QC-in-Series-A-and-Commercial-Expansion SAN DIEGO–(BUSINESS WIRE)–CRISPR QC, a biotechnology start-up based in San Diego, is...
by Xcellerant Ventures | Dec 20, 2023 | Portfolio Company News, Xcellerant Ventures News
Why Xcellerant Ventures Invested in Lenoss Medical The Xcellerant Venture’s team proudly welcomes Lenoss Medical as our 9th portfolio company in Xcellerant Ventures Fund 1. The enthusiasm surrounding their groundbreaking technology is nothing short of exhilarating. In...
by Xcellerant Ventures | Dec 13, 2023 | Portfolio Company News, Xcellerant Ventures News
Origionally posted on Business Wire: https://www.businesswire.com/news/home/20231213775926/en/Xcellerant-Ventures-Invests-in-Series-A-Funding-Round-for-Lenoss-Medical SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Xcellerant Ventures welcomes Lenoss Medical into our...
by Xcellerant Ventures | Nov 10, 2023 | Portfolio Company News
This blog was origionally posted on the Digital Journal and can be viewed here: https://www.digitaljournal.com/tech-science/unraveling-the-value-chain-of-crispr-qc-safeguarding-the-future-of-gene-editing We now live in a world where scientists can edit genes, and...